MYRIAD GENETICS INC Quarterly Operating Lease, Right-of-Use Asset in USD from Q2 2019 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's right to use underlying asset under operating lease.
Summary
Myriad Genetics Inc quarterly Operating Lease, Right-of-Use Asset history and growth rate from Q2 2019 to Q3 2024.
  • Myriad Genetics Inc Operating Lease, Right-of-Use Asset for the quarter ending September 30, 2024 was $57.4M, a 44.8% decline year-over-year.
Operating Lease, Right-of-Use Asset, Quarterly (USD)
Operating Lease, Right-of-Use Asset, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2024 $57.4M -$46.6M -44.8% Sep 30, 2024 10-Q 2024-11-08
Q2 2024 $56.5M -$50.1M -47% Jun 30, 2024 10-Q 2024-08-07
Q1 2024 $58.9M -$48.1M -45% Mar 31, 2024 10-Q 2024-05-08
Q4 2023 $61.6M -$42.3M -40.7% Dec 31, 2023 10-Q 2024-11-08
Q3 2023 $104M -$6.6M -5.97% Sep 30, 2023 10-Q 2023-11-07
Q2 2023 $107M +$23.7M +28.6% Jun 30, 2023 10-Q 2023-08-04
Q1 2023 $107M +$36.1M +50.9% Mar 31, 2023 10-Q 2023-05-04
Q4 2022 $104M +$22.1M +27% Dec 31, 2022 10-K 2024-02-28
Q3 2022 $111M +$27M +32.3% Sep 30, 2022 10-Q 2022-11-02
Q2 2022 $82.9M -$3.7M -4.27% Jun 30, 2022 10-Q 2022-08-05
Q1 2022 $70.9M +$12M +20.4% Mar 31, 2022 10-Q 2022-05-06
Q4 2021 $81.8M +$22.1M +37% Dec 31, 2021 10-K 2023-03-01
Q3 2021 $83.6M +$20.9M +33.3% Sep 30, 2021 10-Q 2021-11-04
Q2 2021 $86.6M +$20.6M +31.2% Jun 30, 2021 10-Q 2021-08-04
Q1 2021 $58.9M -$5.6M -8.68% Mar 31, 2021 10-Q 2021-05-05
Q4 2020 $59.7M -$7.6M -11.3% Dec 31, 2020 10-K 2022-02-25
Q3 2020 $62.7M -$8.6M -12.1% Sep 30, 2020 10-Q 2020-11-09
Q2 2020 $66M +$66M Jun 30, 2020 10-KT 2021-03-16
Q1 2020 $64.5M Mar 31, 2020 10-Q 2020-05-06
Q4 2019 $67.3M Dec 31, 2019 10-Q 2020-02-07
Q3 2019 $71.3M Sep 30, 2019 10-Q 2019-11-06
Q2 2019 $0 Jun 30, 2019 10-KT 2021-03-16
* An asterisk sign (*) next to the value indicates that the value is likely invalid.